SingulOmics is a biotechnology company located in New York, New York, specializing in single-cell omics technology. Situated in the heart of the city at 99 Madison Avenue, the company focuses on advancing the understanding of cellular heterogeneity by providing innovative solutions that enable detailed analysis at the single-cell level. SingulOmics combines expertise in molecular biology, bioinformatics, and advanced instrumentation to offer comprehensive services that support research and development in various biomedical fields.
The company’s work centers on the development and application of cutting-edge techniques designed to analyze the molecular composition of individual cells, which can reveal critical insights into disease mechanisms, drug responses, and cellular functions. By harnessing these technologies, SingulOmics assists researchers, pharmaceutical companies, and academic institutions in generating precise data that contribute to the progress of personalized medicine and targeted therapies. Their approach integrates high-throughput data acquisition with sophisticated computational analysis to ensure robust and reproducible results.
Operating within New York’s vibrant biotech ecosystem, SingulOmics is positioned to collaborate with a diverse network of partners and clients who require specialized expertise in single-cell analysis. The company maintains a commitment to scientific rigor and innovation, striving to support cutting-edge research that addresses complex biological questions. Those interested in exploring their biotechnology services or seeking expert consultation can reach SingulOmics at 929-266-6091 for more detailed information or to discuss potential collaborations.


































